IGI Laboratories Company Profile (NYSE:IG)

Analyst Ratings

Consensus Ratings for IGI Laboratories (NYSE:IG) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $11.00 (43.23% upside)

Analysts' Ratings History for IGI Laboratories (NYSE:IG)
Show:
DateFirmActionRatingPrice TargetActions
10/23/2015Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2015JMP SecuritiesInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/20/2015Oppenheimer Holdings Inc.Reiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2015Avondale PartnersDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2015Deutsche Bank AGInitiated CoverageBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2015Craig HallumReiterated RatingBuy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/24/2014 forward)

Earnings

Earnings History for IGI Laboratories (NYSE:IG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/21/2015        
10/22/2015Q315($0.05)($0.02)$9.36 million$11.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2015Q2($0.08)($0.04)$7.63 million$8.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/2/2015Q414$0.06$0.09$11.88 million$13.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2014($0.01)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2014Q4$0.01($0.01)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/13/2012Q312($0.04)$2.11 million$1.98 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for IGI Laboratories (NYSE:IG)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for IGI Laboratories (NYSE:IG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for IGI Laboratories (NYSE:IG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
9/1/2015Jason Grenfell-GardnerCEOSell84,048$7.94$667,341.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/30/2015James C GaleDirectorBuy30,000$5.04$151,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/5/2015Sciences Opportunities Fu LifeMajor ShareholderSell2,000,000$9.95$19,900,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Sciences Opportunities Fu LifeMajor ShareholderSell2,000,000$6.45$12,900,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Sciences Opportunities Fu LifeMajor ShareholderSell3,000,000$6.20$18,600,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2014James C GaleDirectorBuy5,000$5.90$29,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/4/2014Jason Grenfell-GardnerCEOSell66,828$5.85$390,943.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2014Joyce EronyDirectorSell17,500$5.48$95,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/6/2013Michael B HemricDirectorBuy50,000$1.48$74,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2013Jason Grenfell-GardnerCEOBuy3,500$1.55$5,425.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2013James C GaleDirectorBuy10,000$1.33$13,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2013Michael B HemricDirectorBuy20,637$1.19$24,558.03View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2012Jason Grenfell-GardnerCEOBuy10,000$1.15$11,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for IGI Laboratories (NYSE:IG)
DateHeadline
07/12/16 04:52 PMIGI Laboratories, Inc. (IG) Updated Price Targets - FTSE News
07/09/16 07:59 AMTeligent Receives FDA Approval For Two Topical Prescription Products (NASDAQ:TLGT) - Consumer Eagle
07/07/16 04:41 PMTeligent Inc Stock Price Increases Today - Engelwood Daily
07/07/16 04:41 PMTeligent Inc Stock Price Increases Today - Engelwood Daily
07/07/16 07:28 AMA Reversal for Teligent Inc Is Not Near. The Stock Rises Again - Engelwood Daily
07/05/16 04:28 PMStocks Buzz: Agilent Technologies (A), Waddell & Reed (WDR), Parker Hannifin (NYSE:PH) - iStreetWire
07/02/16 04:27 PMTeligent Incorporated (NASDAQ:TLGT) Shorted Shares Decreased By 0.1% - Engelwood Daily
06/30/16 04:51 PMRaymond James Initiates Coverage on Teligent Inc to Strong Buy - Trade Calls
06/27/16 04:33 PMBuena pharmaceutical firm tripling plant, doubling jobs - Press of Atlantic City
06/25/16 04:17 PMTeligent (NASDAQ:TLGT) stock price target held steady to $0 as covered today by Raymond James
06/14/16 04:26 PMRecently Issued Stock Ratings For IGI Laboratories, Inc. (IG) - Fiscal Standard
06/03/16 07:15 AMNew Broker Ratings For IGI Laboratories, Inc. (IG) - FTSE News - New Broker Ratings For IGI Laboratories, Inc. (IG)FTSE News04/07/2015 – Deutsche Bank began new coverage on IGI Laboratories, Inc. giving the company a “buy” rating. They now have a USD 10 price target on the stock. 11/07/2014 – IGI Laboratories, Inc. had its “outperform” rating reiterated by analysts at ...
06/02/16 07:21 AMIGI Laboratories, Inc. (IG) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News - IGI Laboratories, Inc. (IG) Do Brokers Advise Buy, Sell Or Hold?Share Trading NewsMarket analysts have recently updated their ratings and price targets on shares of IGI Laboratories, Inc. (IG). The latest reports which are currently in issue on Thursday 2nd of June state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...and more »
05/30/16 10:51 PMTeligent Incorporated (NASDAQ:TLGT) Sellers Covered 0.58% of Their Shorts - HNN - Teligent Incorporated (NASDAQ:TLGT) Sellers Covered 0.58% of Their ShortsHNNAbout 182,148 shares traded hands. Teligent Inc (NASDAQ:TLGT) has risen 6.00% since April 30, 2016 and is uptrending. It has outperformed by 3.73% the S&P500. Teligent, Inc., formerly IGI Laboratories, Inc., is a specialty generic pharmaceutical company.
05/06/16 06:45 AMIGI Laboratories, Inc. (IG) Updated Broker Price Targets - Share Trading News - IGI Laboratories, Inc. (IG) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of IGI Laboratories, Inc. (IG). The latest reports which are currently in issue on Thursday 5th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...
04/22/16 07:25 AMIGI Laboratories, Inc. (IG) Updated Analyst Coverage - Risers & Fallers - IGI Laboratories, Inc. (IG) Updated Analyst CoverageRisers & FallersA number of investment brokers have recently updated their price targets on shares of IGI Laboratories, Inc. (IG). According to the latest broker reports outstanding on Friday 22nd of April, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...
04/20/16 08:00 AMIGI Laboratories, Inc. (IG) - Broker Update - Risers & Fallers - IGI Laboratories, Inc. (IG) - Broker UpdateRisers & FallersBelow are the most recently updated broker updates which include ratings and price targets for IGI Laboratories, Inc. (IG). 10/24/2015 – Broker: Roth Capital Rating: buy reiteration. 09/09/2015 – Broker: JMP Securities Rating: market perform newcoverage.
04/17/16 06:15 AMTeligent Inc Just Recorded A Sigfniciant Increase - Stock Caller - Teligent Inc Just Recorded A Sigfniciant IncreaseStock Caller... develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc ...
04/13/16 12:42 PMAnalyst Coverage: IGI Laboratories, Inc. (IG) - Risers & Fallers - Analyst Coverage: IGI Laboratories, Inc. (IG)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of IGI Laboratories, Inc. (IG). The latest broker reports which are currently outstanding on Tuesday 12th of April state 0 analysts have a rating of “strong buy”, 0 analysts ...
04/09/16 09:48 AMIGI Laboratories, Inc. (IG) Analyst Review - Risers & Fallers - IGI Laboratories, Inc. (IG) Analyst ReviewRisers & FallersA number of investment brokers have recently updated their price targets on shares of IGI Laboratories, Inc. (IG). According to the latest broker reports outstanding on Friday 8th of April, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...
04/05/16 11:59 AMTeligent Incorporated (NASDAQ:TLGT) Shorts Decreased by 2.54% After Short Covering - RiversideGazette.com - Teligent Incorporated (NASDAQ:TLGT) Shorts Decreased by 2.54% After Short CoveringRiversideGazette.comTeligent, Inc., formerly IGI Laboratories, Inc., is a specialty generic pharmaceutical company. The company has a market cap of $285.71 million. The Firm is engaged in the manufacture and development of topical pharmaceutical, over-the-counter and ...and more »
04/04/16 01:58 PMBroker Changes For IGI Laboratories, Inc. (IG) - Risers & Fallers - Broker Changes For IGI Laboratories, Inc. (IG)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of IGI Laboratories, Inc. (IG). The latest broker reports which are currently outstanding on Monday 4th of April state 0 analysts have a rating of “strong buy”, 0 analysts ...and more »
04/03/16 12:10 PMIGI Laboratories, Inc. (IG) Broker Price Targets For The Coming Week - Share Trading News - IGI Laboratories, Inc. (IG) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of IGI Laboratories, Inc. (IG). The latest reports which are currently in issue on Sunday 3rd of April state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...and more »
04/02/16 10:50 AMDiamond Detectives - Rapaport - Diamond DetectivesRapaportAs lab-grown diamonds grow bigger and better with technological improvements, the need for better detection of such diamonds grows as well. Some people in the diamond trade worry about unscrupulous traders trying to pass off lab-grown diamonds as ...
04/01/16 12:26 PMLatest Price Targets For IGI Laboratories, Inc. (IG) - Share Trading News - Latest Price Targets For IGI Laboratories, Inc. (IG)Share Trading NewsThe most recently updated broker views and price targets issued for IGI Laboratories, Inc. (IG) are below. 10/24/2015 – Broker: Roth Capital Rating: buy reiteration. 09/09/2015 – Broker: JMP Securities Rating: market perform newcoverage. 07/20/2015 ...
03/31/16 12:54 PMTeligent, Inc. Appoints Dr. Carole Ben-Maimon To Board Of Directors - PR Newswire (press release) - Teligent, Inc. Appoints Dr. Carole Ben-Maimon To Board Of DirectorsPR Newswire (press release)These statements are based on our current beliefs or expectations and are inherently subject to various risks and uncertainties, including those set forth under the caption "Risk Factors" in IGI Laboratories, Inc.'s most recent Annual Report on Form 10 ...and more »
03/30/16 11:52 AMIGI LABORATORIES INC (NYSE:IG) rating of Reiterated Rating confirmed by Roth Capital - Hints News Network - IGI LABORATORIES INC (NYSE:IG) rating of Reiterated Rating confirmed by Roth CapitalHints News NetworkIGI LABORATORIES INC (NYSE:IG) opened at $ on Friday. The firm's 50-day moving average is $7.71 and it's 200-day moving average is $7.24. The firm has a mkt cap of $ and a price-to-earnings ratio of . IGI LABORATORIES INC has a annual low of $4.75 ...and more »
03/25/16 12:43 PMTeligent Incorporated (NASDAQ:TLGT) Short Interest Decreased By 6.19% - Clinton Financial - Teligent Incorporated (NASDAQ:TLGT) Short Interest Decreased By 6.19%Clinton FinancialTeligent, Inc., formerly IGI Laboratories, Inc., is a specialty generic pharmaceutical company. The company has a market cap of $242.31 million. The Firm is engaged in the manufacture and development of topical pharmaceutical, over-the-counter and ...and more »
03/24/16 01:28 PMIGI Laboratories, Inc. (IG) Updated Price Targets - Share Trading News - IGI Laboratories, Inc. (IG) Updated Price TargetsShare Trading News04/07/2015 – Deutsche Bank began new coverage on IGI Laboratories, Inc. giving the company a “buy” rating. They now have a USD 10 price target on the stock. 11/07/2014 – IGI Laboratories, Inc. had its “outperform” rating reiterated by analysts at ...
03/21/16 01:10 PMTeligent, Inc. Announces Launch Of Cefotan® (Cefotetan For Injection) - PR Newswire (press release) - Teligent, Inc. Announces Launch Of Cefotan® (Cefotetan For Injection)PR Newswire (press release)These statements are based on our current beliefs or expectations and are inherently subject to various risks and uncertainties, including those set forth under the caption "Risk Factors" in IGI Laboratories, Inc.'s most recent Annual Report on Form 10 ...Is Selling 52-Week Stock Like Teligent Inc a Winning Strategy?SmallCapWired.comall 3 news articles »
03/20/16 12:27 PMDeutsche Bank Maintains Teligent Inc to Hold with Price Target $8.00 - Street Edition - Deutsche Bank Maintains Teligent Inc to Hold with Price Target $8.00Street EditionTeligent Inc. formerly IGI Laboratories Inc. is a specialty generic pharmaceutical company. The Company is engaged in the manufacture and development of topical pharmaceutical over-the-counter (OTC) and cosmetic products. The Company under its label ...and more »
03/20/16 12:27 PMWith Volume of583158, Igi Laboratories Incorporated (NYSEMKT:IG) performance is mixed - The Duncan Independent (press release) (blog) - With Volume of583158, Igi Laboratories Incorporated (NYSEMKT:IG) performance is mixedThe Duncan Independent (press release) (blog)IGI Laboratories, Inc. (IGI) develops, manufactures, fills and packs topical semi-solid and liquid products for cosmetic, cosmeceutical and pharmaceutical customers. The Company's products are used for a variety of skin conditions, including the ...
03/17/16 11:30 AMIgi Laboratories Incorporated – Will NYSEMKT:IG be able to hit earnings expectations? - The Duncan Independent (press release) (blog) - Igi Laboratories Incorporated – Will NYSEMKT:IG be able to hit earnings expectations?The Duncan Independent (press release) (blog)IGI Laboratories, Inc. (IGI) develops, manufactures, fills and packs topical semi-solid and liquid products for cosmetic, cosmeceutical and pharmaceutical customers. The Company's products are used for a variety of skin conditions, including the ...and more »
03/15/16 09:07 PMUpdated Price Targets On IGI Laboratories, Inc. (IG) - Risers & Fallers - Updated Price Targets On IGI Laboratories, Inc. (IG)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of IGI Laboratories, Inc. (IG). The latest broker reports which are currently outstanding on Monday 14th of March state 0 analysts have a rating of “strong buy”, 0 analysts ...
03/09/16 12:34 PMNew Price Targets On IGI Laboratories, Inc. (IG) - Risers & Fallers - New Price Targets On IGI Laboratories, Inc. (IG)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of IGI Laboratories, Inc. (IG). The latest broker reports which are currently outstanding on Wednesday 9th of March state 0 analysts have a rating of “strong buy”, 0 analysts ...
03/02/16 12:54 PMCurrent Price Targets On IGI Laboratories, Inc. (IG) - Risers & Fallers - Current Price Targets On IGI Laboratories, Inc. (IG)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of IGI Laboratories, Inc. (IG). The latest broker reports which are currently outstanding on Tuesday 1st of March state 0 analysts have a rating of “strong buy”, 0 analysts ...and more »
02/29/16 07:53 PMTeligent Inc on Focus After Crashing In Today's Session - Business Standard Tribune - Teligent Inc on Focus After Crashing In Today's SessionBusiness Standard Tribune... develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc ...
02/27/16 12:22 PMChanges To Broker Targets On IGI Laboratories, Inc. (IG) - Share Trading News - Changes To Broker Targets On IGI Laboratories, Inc. (IG)Share Trading News04/07/2015 – Deutsche Bank began new coverage on IGI Laboratories, Inc. giving the company a “buy” rating. They now have a USD 10 price target on the stock. 11/07/2014 – IGI Laboratories, Inc. had its “outperform” rating reiterated by analysts at ...
02/22/16 06:35 PMIgi Laboratories, Inc. Company Profile - IGI is betting big on small things. It manufactures creams, liquids, and other topical products for drug and cosmetics companies using its microencapsulation technology. IGI originally licensed the technology, dubbed Novasome, from drug firm Novovax.
02/19/16 11:38 AMTeligent Incorporated (NASDAQ:TLGT) Shorts Decreased by 3.07% After Short Covering - fdanewsalert.com - Teligent Incorporated (NASDAQ:TLGT) Shorts Decreased by 3.07% After Short Coveringfdanewsalert.comThe stock of Teligent Incorporated (NASDAQ:TLGT) registered a decrease of 3.07% in short interest. TLGT's total short interest was 10.34M shares in February as published by FINRA. Its down 3.07% from 10.66M shares, reported previously. With 339,000 ...834166 Shares in Teligent Inc (TLGT) Acquired by Summit Creek AdvisorsIntercooler Financialall 2 news articles »
02/03/16 09:57 AMTeligent Shares Rise 6% on US FDA Approval For Lidocaine Ointment USP 5% (NASDAQ:TLGT) - WallStreet.org - Teligent Shares Rise 6% on US FDA Approval For Lidocaine Ointment USP 5% (NASDAQ:TLGT)WallStreet.orgThe company was formerly known as IGI Laboratories, Inc. and changed its name to Teligent, Inc. in October 2015. Teligent, Inc. was founded in 1977 and is based in Buena, New Jersey. Teligent Inc - Receive News & Ratings Via Email - Enter your email ...1823861 Shares in Teligent Inc (TLGT) Acquired by AMI Asset Management CorpCorvus Business Newswireall 5 news articles »
02/02/16 09:59 AMCourt Report - January 2016 #4 - JD Supra (press release) - Court Report - January 2016 #4JD Supra (press release)Plaintiffs: Horizon Pharma Ireland Ltd.; HZNP Limited; Horizon Pharma USA, Inc. • Defendants: Actavis Laboratories UT, Inc.; Actavis, Inc.; Allergan PLC. Horizon Pharma Ireland Ltd. et al. v. IGI Laboratories, Inc. 1:15-cv-06991; filed September 17 ...and more »
01/31/16 09:36 AMHelix BioPharma Corp. Announces Appointment of New Directors to the Board of Directors - SYS-CON Media (press release) - Helix BioPharma Corp. Announces Appointment of New Directors to the Board of DirectorsSYS-CON Media (press release)Mr. Albert Beraldo is the former founder/ President and CEO of Alveda Pharmaceuticals Inc., a privately owned Canadian company that is a leading supplier of pharmaceuticals to the Canadian health care market. IGI Laboratories, Inc., a New Jersey-based ...and more »
01/30/16 04:48 PMHelix BioPharma Corp. Announces Appointment of New Directors to the Board of Directors - Yahoo Finance UK - Helix BioPharma Corp. Announces Appointment of New Directors to the Board of DirectorsYahoo Finance UKMr. Albert Beraldo is the former founder/ President and CEO of Alveda Pharmaceuticals Inc., a privately owned Canadian company that is a leading supplier of pharmaceuticals to the Canadian health care market. IGI Laboratories, Inc., a New Jersey-based ...and more »
01/30/16 09:33 AMHelix BioPharma Corp. Announces Appointment of New Directors to the Board of Directors - Benzinga - Helix BioPharma Corp. Announces Appointment of New Directors to the Board of DirectorsBenzingaMr. Albert Beraldo is the former founder/ President and CEO of Alveda Pharmaceuticals Inc., a privately owned Canadian company that is a leading supplier of pharmaceuticals to the Canadian health care market. IGI Laboratories, Inc., a New Jersey-based ...and more »
12/04/15 05:05 AMTELIGENT, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits -
11/27/15 06:08 AMShould You Buy Addus Homecare Corporation (ADUS)? -
10/29/15 12:04 PMTELIGENT, INC. Financials -
10/14/15 07:18 AMIGI LABORATORIES, INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stand -
10/14/15 07:00 AMIGI Laboratories Announces Approval For Listing On The NASDAQ Global Select Market -

Social

About IGI Laboratories

IGI Laboratories logoIGI Laboratories, Inc. is a specialty generic pharmaceutical company. Under its IGI label, the Company sells generic topical pharmaceutical products that are bioequivalent to their brand name counterparts. The Company provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. The Company has two platforms for growth: developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its current contract manufacturing and formulation services business. The Company also develops, manufactures, fills and packages topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as the OTC and cosmetic markets. These products are used in a range of applications from cosmetics to the prescription treatment of conditions like dermatitis, psoriasis and eczema.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: IG
  • CUSIP:
Key Metrics:
  • Previous Close: $7.68
  • 50 Day Moving Average: $7.71
  • 200 Day Moving Average: $7.24
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $N/A
  • Current Year EPS Consensus Estimate: $-0.08 EPS
  • Next Year EPS Consensus Estimate: $0.12 EPS
Additional Links:
IGI Laboratories (NYSE:IG) Chart for Sunday, July, 24, 2016